Literature DB >> 11893563

TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling.

William S Bradham1, Gordon Moe, Katherine A Wendt, Amelia A Scott, Andrea Konig, Marina Romanova, George Naik, Francis G Spinale.   

Abstract

The cytokine tumor necrosis factor (TNF)-alpha has been causally linked to left ventricular (LV) remodeling, but the molecular basis for this effect is unknown. Matrix metalloproteinases (MMPs) have been implicated in cardiac remodeling and can be regulated by TNF-alpha. This study tested the central hypothesis that administration of a TNF-alpha blocking protein would prevent the induction of MMPs and alter the course of myocardial remodeling in developing LV failure. Adult dogs were randomly assigned to the following groups: 1) chronic pacing (250 beats/min, 28 days, n = 12), 2) chronic pacing with concomitant administration of a TNF-alpha blocking protein (TNF block) using a soluble p75 TNF receptor fusion protein (TNFR:Fc; administered at 0.5 mg/kg twice a week subcutaneously, n = 7), and 3) normal controls (n = 10). LV end-diastolic volume increased from control with chronic pacing (83 +/- 12 vs. 118 +/- 10 ml, P < 0.05) and was reduced with TNF block (97 +/- 9 ml, P < 0.05). MMP zymographic levels (92 kDa, pixels) increased from control with chronic pacing (36,848 +/- 9,593 vs. 87,247 +/- 12,912, P < 0.05) and was normalized by TNF block. Myocardial MMP-9 and MMP-13 levels by immunoblot increased with chronic pacing relative to controls (130 +/- 10% and 118 +/- 6%, P < 0.05) and was normalized by TNF block. These results provide evidence to suggest that TNF-alpha contributes to the myocardial remodeling process in evolving heart failure through the local induction of specific MMPs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11893563     DOI: 10.1152/ajpheart.00526.2001

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  39 in total

Review 1.  Clinical implications of matrix metalloproteinases.

Authors:  Malay Mandal; Amritlal Mandal; Sudip Das; Tapati Chakraborti; Chakraborti Sajal
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

2.  Helix-loop-helix protein p8, a transcriptional regulator required for cardiomyocyte hypertrophy and cardiac fibroblast matrix metalloprotease induction.

Authors:  Sandro Goruppi; Richard D Patten; Thomas Force; John M Kyriakis
Journal:  Mol Cell Biol       Date:  2006-11-20       Impact factor: 4.272

3.  Effects of Tribuli saponins on left ventricular remodeling after acute myocardial infarction in rats with hyperlipidemia.

Authors:  Yan Guo; Hui-jun Yin; Da-zhuo Shi; Ke-ji Chen
Journal:  Chin J Integr Med       Date:  2005-06       Impact factor: 1.978

4.  Absence of Fibrosis and Inflammation by Cardiac Magnetic Resonance Imaging in Rheumatoid Arthritis Patients with Low to Moderate Disease Activity.

Authors:  William Bradham; Michelle J Ormseth; Comfort Elumogo; Srikanth Palanisamy; Chia-Ying Liu; Mark A Lawson; Jonathan H Soslow; Nadine Kawel-Boehm; David A Bluemke; C Michael Stein
Journal:  J Rheumatol       Date:  2018-04-15       Impact factor: 4.666

5.  Regulation of matrix metalloproteinases is at the heart of myocardial remodeling.

Authors:  Scott P Levick; Gregory L Brower
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-29       Impact factor: 4.733

6.  Generating double knockout mice to model genetic intervention for diabetic cardiomyopathy in humans.

Authors:  Vishalakshi Chavali; Shyam Sundar Nandi; Shree Ram Singh; Paras Kumar Mishra
Journal:  Methods Mol Biol       Date:  2014

Review 7.  Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver.

Authors:  Hassan K Awada; Mintai P Hwang; Yadong Wang
Journal:  Biomaterials       Date:  2015-12-29       Impact factor: 12.479

8.  Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study.

Authors:  Andreas Kalogeropoulos; Vasiliki Georgiopoulou; Bruce M Psaty; Nicolas Rodondi; Andrew L Smith; David G Harrison; Yongmei Liu; Udo Hoffmann; Douglas C Bauer; Anne B Newman; Stephen B Kritchevsky; Tamara B Harris; Javed Butler
Journal:  J Am Coll Cardiol       Date:  2010-05-11       Impact factor: 24.094

9.  Soluble tumor necrosis factor receptors and heart failure risk in older adults: Health, Aging, and Body Composition (Health ABC) Study.

Authors:  Catherine N Marti; Hassan Khan; Douglas L Mann; Vasiliki V Georgiopoulou; Kirsten Bibbins-Domingo; Tamara Harris; Annemarie Koster; Anne Newman; Stephen B Kritchevsky; Andreas P Kalogeropoulos; Javed Butler
Journal:  Circ Heart Fail       Date:  2013-12-09       Impact factor: 8.790

10.  Molecular pathogenetic mechanisms and new therapeutic perspectives in anthracycline-induced cardiomyopathy.

Authors:  Giuseppe Distefano
Journal:  Ital J Pediatr       Date:  2009-11-20       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.